Access 2.8M+ Filings Sign Up Free
ILIKA PLC Logo

ILIKA PLC | IGE - Profile, Filings, Stock Info & Investor Relations Data

ILIKA PLC | IGE
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Pharmaceuticals
Country
United Kingdom
Founded
N/A
ILIKA PLC (IGE)

Company Profile

About ILIKA PLC

ImmuPharma is an AIM-listed biopharmaceutical company developing peptide-based therapies for autoimmune diseases and anti-infectives.Ê Its lead program, P140, is in Phase 3 trials for SLE.Ê The company aims to build a robust pipeline through strategic partnerships and licensing, maximizing shareholder value.

Headquarters

UNIT 10A, THE QUADRANGLE
SO51 9DL, ROMSEY
United Kingdom

ILIKA PLC (IGE)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Get Notified About ILIKA PLC's New Filings

Receive email alerts when new documents are published.

You can unsubscribe at any time.

ILIKA PLC (IGE)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

No Insider Trades

There is currently no insider trading data available for this company.

ILIKA PLC (IGE)
Stock & Investor Information

ISINs

GB00B608Z994
GB00BRJRY971
GB00BRJRYB91

LEI

213800TMDNIE3Z8XXD26

Stock Exchange Listings

London Stock Exchange

Stock Index Memberships

AIM (LSE)

Industry Classification

Sector
Health Care
Industry
Pharmaceuticals